Identification of Human Single-Domain Antibodies against SARS-CoV-2

The worldwide spread of COVID-19 highlights the need for an efficient approach to rapidly develop therapeutics and prophylactics against SARS-CoV-2. The SARS-CoV-2 spike protein, containing the receptor-binding domain (RBD) and S1 subunit involved in receptor engagement, is a potential therapeutic t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cell Host Microbe
Huvudupphovsmän: Wu, Yanling, Li, Cheng, Xia, Shuai, Tian, Xiaolong, Kong, Yu, Wang, Zhi, Gu, Chenjian, Zhang, Rong, Tu, Chao, Xie, Youhua, Yang, Zhenlin, Lu, Lu, Jiang, Shibo, Ying, Tianlei
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier Inc. 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7224157/
https://ncbi.nlm.nih.gov/pubmed/32413276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chom.2020.04.023
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk